Correlation Between Ceragon Networks and Raphael Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Ceragon Networks and Raphael Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ceragon Networks and Raphael Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ceragon Networks and Raphael Pharmaceutical, you can compare the effects of market volatilities on Ceragon Networks and Raphael Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ceragon Networks with a short position of Raphael Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ceragon Networks and Raphael Pharmaceutical.

Diversification Opportunities for Ceragon Networks and Raphael Pharmaceutical

-0.34

Correlation Coefficient

Ceragon Networks  Raphael Pharmaceutical

Very good diversification

The 3 months correlation between Ceragon and Raphael is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Ceragon Networks and Raphael Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Raphael Pharmaceutical and Ceragon Networks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ceragon Networks are associated (or correlated) with Raphael Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Raphael Pharmaceutical has no effect on the direction of Ceragon Networks i.e., Ceragon Networks and Raphael Pharmaceutical go up and down completely randomly.

Pair Corralation between Ceragon Networks and Raphael Pharmaceutical

Given the investment horizon of 90 days Ceragon Networks is expected to generate 0.39 times more return on investment than Raphael Pharmaceutical. However, Ceragon Networks is 2.57 times less risky than Raphael Pharmaceutical. It trades about 0.18 of its potential returns per unit of risk. Raphael Pharmaceutical is currently generating about -0.13 per unit of risk. If you would invest  289.00  in Ceragon Networks on September 5, 2024 and sell it today you would earn a total of  150.00  from holding Ceragon Networks or generate 51.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ceragon Networks  vs.  Raphael Pharmaceutical

Ceragon Networks

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ceragon Networks are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Ceragon Networks unveiled solid returns over the last few months and may actually be approaching a breakup point.

Raphael Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Raphael Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Ceragon Networks and Raphael Pharmaceutical

The main advantage of trading using opposite Ceragon Networks and Raphael Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ceragon Networks position performs unexpectedly, Raphael Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Raphael Pharmaceutical will offset losses from the drop in Raphael Pharmaceutical's long position.

The idea behind Ceragon Networks and Raphael Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.